Search the Newsreel

Prestige Consumer Healthcare (NYSE:PBH) Upgraded by Zacks Research to "Hold" Rating

Zacks Research has upgraded Prestige Consumer Healthcare (NYSE:PBH) from a "strong sell" to a "hold" rating. This upgrade comes after the company exceeded quarterly earnings expectations, reporting $0.98 EPS against a $0.89 consensus and revenue of $265.71 million, a 6.5% increase year-over-year. The consensus …

Premium Brands Holdings (TSX:PBH) Is Down 12.1% After Cutting 2026 Revenue Outlook and Delaying U.S. Launches

Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH

Renaissance Technologies LLC significantly reduced its stake in Prestige Consumer Healthcare Inc. (PBH) by 62% in the first quarter, selling 59,900 shares but retaining 36,702 shares valued at approximately $2.17 million. Despite this, institutional investors collectively own 99.95% of PBH. Prestige Consumer Healthcare reported …

Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH

Quantinno Capital Management LP significantly increased its stake in Prestige Consumer Healthcare Inc. (PBH) by acquiring 19,281 shares, bringing its total holdings to 36,990 shares valued at $2.19 million. Institutional investors collectively own 99.95% of PBH. The company also surpassed quarterly earnings expectations, reporting …

Prestige Consumer Healthcare (PBH) Is Up 5.6% After Raising Fiscal 2027 Outlook on Acquisitions

Prestige Consumer Healthcare (PBH) saw its stock rise by 5.6% after reporting its fiscal 2027 first-quarter results and subsequently raising its full-year outlook. The company's updated revenue guidance of US$1.29 billion–US$1.32 billion and GAAP diluted EPS guidance of US$4.18–US$4.28 are primarily driven by recent …

Prestige Consumer Executives Set for Aug. 12 Fireside Chat

Prestige Consumer Healthcare Inc. (NYSE: PBH) announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at …

Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference

Prestige Consumer Healthcare Inc. announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. The event is scheduled for Wednesday, August …

Prestige Consumer Healthcare (PBH) Following Its 2027 Outlook Raise And The Undervalued View

Prestige Consumer Healthcare (PBH) has raised its fiscal 2027 revenue and earnings outlook, projecting revenue between $1.29b and $1.32b and GAAP diluted EPS between $4.18 and $4.28, driven by the integration of two recent acquisitions. Despite a mixed share price performance over the past …

Prestige Consumer Healthcare (PBH) Stock Faces Margin Questions Despite Record Cash Flow

Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions

In early August 2026, Prestige Consumer Healthcare reported fiscal 2027 first‑quarter revenue of US$265.71 million, up from US$249.53 million a year earlier, and raised its full‑year 2027 revenue outlook to US$1.29 billion–US$1.32 billion and projected GAAP diluted EPS of US$4.18–US$4.28, reflecting the addition of …

Prestige Consumer Healthcare Inc. $PBH Shares Bought by First Trust Advisors LP

First Trust Advisors LP significantly increased its stake in Prestige Consumer Healthcare Inc. (PBH) by 137.5% in the first quarter, now owning 37,395 shares valued at approximately $2.2 million. The company exceeded quarterly expectations with adjusted EPS of $0.98 and revenue of $265.7 million, …

Premium Brands Holdings (TSX:PBH) Stock Faces Margin Squeeze Despite Revenue Surge

What Is Driving Fresh Interest In Premium Brands (TSX:PBH)?

Desjardins Has Lowered Expectations for Premium Brands (TSE:PBH) Stock Price

Canadian Imperial Bank of Commerce Cuts Premium Brands (TSE:PBH) Price Target to C$100.00

Ventum Issues Pessimistic Forecast for Premium Brands (TSE:PBH) Stock Price

Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call Highlights: Record Cash Flow and ...

Prestige Consumer Healthcare Inc. (PBH) reported exceeding sales and earnings expectations in Q1 fiscal 2027, with total sales up 6.5% to $266 million and record adjusted free cash flow of $83.7 million. The company successfully integrated the Breathe Right acquisition and completed another strategic …

Prestige Consumer Healthcare Stock (PBH) Opinions on Recent Earnings and M&A Activity

Breathe Right and LaCorium Acquisitions Raise Prestige Consumer's 2027 Outlook

Prestige Consumer Healthcare reported strong Q1 fiscal 2027 results with revenue up 6.5% to $265.7 million and adjusted diluted EPS rising to $0.98. The company's recent acquisitions of Breathe Right and LaCorium Health significantly contributed to these results and led to a raised fiscal …

National Bank Financial Has Lowered Expectations for Premium Brands (TSE:PBH) Stock Price

Prestige Consumer Healthcare Inc. 2026: Revenue $265.71M, EPS $0.61— 10-Q Summary

Prestige Consumer Healthcare Inc. reported a Q2 2026 revenue increase to $265.71M, up 6.5% year-over-year, driven by growth in both North America and International markets. Despite revenue growth, net income and diluted EPS declined by 38.5% and 35.8% respectively compared to the prior-year quarter. …

Prestige Consumer Healthcare (NYSE: PBH) expands with $1,045.0M wellness deal

Prestige Consumer Healthcare Inc. (NYSE: PBH) reported its Q1 2027 earnings, revealing a 6.5% increase in total revenues to $265.7 million for the quarter ended June 30, 2026, primarily driven by the $1,045.0 million acquisition of the OTC Wellness Business, including the Breathe Right …

Earnings call transcript: Prestige Consumer beats Q1 2026 estimates as stock edges higher

Prestige Consumer Healthcare reported stronger-than-expected Q1 fiscal 2027 results, with adjusted EPS of $0.98 and revenue of $265.7 million, both exceeding analyst estimates. The company saw organic revenue growth of 3.2% and a record adjusted free cash flow of $83.7 million, while integrating the …

Premium Brands Holdings Corp (PRBZF) (Q2 2026) Earnings Call Highlights: Record Sales and Free ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record Q2 sales of $2.4 billion, up 26.3% year-over-year, driven by acquisitions and organic growth. …

Prestige Consumer Healthcare Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:PBH) 2026-08-06

Prestige Consumer Healthcare Inc. (PBH) has released its Q1 2027 earnings call presentation. The company reported an EPS of $0.98, beating estimates by $0.10, and revenue of $265.71M, surpassing expectations by $15.39M, representing a 6.48% year-over-year increase. This article provides access to the slide …

Earnings Flash (PBH.TO) Premium Brands Posts Q2 Adjusted CEPS $1.53 vs. FactSet Est of C$1.56

Earnings Flash (PBH.TO) Premium Brands Holdings Reports Q2 Revenue C$2.38B, vs. FactSet Est of C$2.39B

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare (NYSE: PBH) awards director 2,981 RSUs

Prestige Consumer Healthcare (NYSE: PBH) director Dawn M. Zier was granted 2,981 restricted stock units (RSUs) as part of the company's director compensation program. The RSUs, valued at $155,000 based on a $52.00 closing stock price, will vest on the first anniversary of the …

PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD SECOND QUARTER SALES, ADJUSTED EBITDA AND ADJUSTED EARNINGS AND DECLARES THIRD QUARTER DIVIDEND

VANCOUVER, BC, Aug. 6, 2026 /CNW/ -- Premium Brands Holdings Corporation (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, announced today its results for the second quarter of 2026. QUARTER HIGHLIGHTS Record second quarter revenue of $2.4 billion representing …

Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Reports Q1 Revenue $265.7M, vs. FactSet Est of $250.3M

Prestige Consumer Healthcare Inc. (PBH) reported its Q1 revenue of $265.7 million, surpassing FactSet's estimate of $250.3 million. This positive earnings flash was published on August 6, 2026, and also follows an earlier report of the company raising its earnings guidance for fiscal year …

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Prestige Consumer Healthcare Inc. reported strong first-quarter fiscal 2027 results, exceeding sales and earnings expectations with a revenue of $265.7 million, up 6.5%, and organic sales growth of 3.2%. The company closed the Breathe Right® and LaCorium acquisitions, which contributed to its performance and …

Premium Brands (PBH) Earnings Date and Reports 2026 $PBH